Louisiana · 2026 Regular Session · Bill

HB 920: INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

In committee Last action March 9, 2026: Read by title, under the rules, referred to the Committee on Insurance.

Plain-language summary

HB 920 is a bill introduced in the Louisiana House on February 27, 2026. According to its official title, it concerns: INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note). Primary sponsor: Edmond Jordan (Democratic). Most recent recorded action (March 9, 2026): Read by title, under the rules, referred to the Committee on Insurance.

Sponsors

Primary sponsor: Edmond Jordan (Democratic).